380
Views
27
CrossRef citations to date
0
Altmetric
Review

Anticalins as an alternative to antibody technology

&
Pages 1453-1462 | Published online: 30 Nov 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Karolina Pierzynowska, Joanna Morcinek-Orłowska, Lidia Gaffke, Weronika Jaroszewicz, Piotr M. Skowron & Grzegorz Węgrzyn. (2023) Applications of the phage display technology in molecular biology, biotechnology and medicine. Critical Reviews in Microbiology 0:0, pages 1-41.
Read now
Abdul Rasheed Baloch, Abdul Wahid Baloch, Brian J. Sutton & Xiaoying Zhang. (2016) Antibody mimetics: promising complementary agents to animal-sourced antibodies. Critical Reviews in Biotechnology 36:2, pages 268-275.
Read now

Articles from other publishers (25)

Louise Rosenmayr-Templeton. (2021) Industry news update covering May 2021. Therapeutic Delivery 12:9, pages 637-644.
Crossref
Zhaoyong Xi, Xianglei Liu, Rui Lin, John D. Persons, Tatiana V. Ilina, Wei Li, Dimiter S. Dimitrov & Rieko Ishima. (2021) The reduced form of the antibody CH2 domain . Protein Science 30:9, pages 1895-1903.
Crossref
Ben J. Glasgow. (2021) Tear Lipocalin and Lipocalin-Interacting Membrane Receptor. Frontiers in Physiology 12.
Crossref
T. Sécher, L. Guilleminault, K. Reckamp, I. Amanam, L. Plantier & N. Heuzé-Vourc'h. (2018) Therapeutic antibodies: A new era in the treatment of respiratory diseases?. Pharmacology & Therapeutics 189, pages 149-172.
Crossref
Madduri Srinivasarao & Philip S. Low. (2017) Ligand-Targeted Drug Delivery. Chemical Reviews 117:19, pages 12133-12164.
Crossref
Asim Azhar, Ejaj Ahmad, Qamar Zia, Mohd. Ahmar Rauf, Mohammad Owais & Ghulam Md Ashraf. (2017) Recent advances in the development of novel protein scaffolds based therapeutics. International Journal of Biological Macromolecules 102, pages 630-641.
Crossref
Abhinav A. Shukla, Leslie S. Wolfe, Sigma S. Mostafa & Carnley Norman. (2017) Evolving trends in mAb production processes. Bioengineering & Translational Medicine 2:1, pages 58-69.
Crossref
A.A. Shukla, L. Wolfe & C. Norman. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 171 179 .
Javad Hamedi, Naghmeh Poorinmohammad & Joachim Wink. 2017. Biology and Biotechnology of Actinobacteria. Biology and Biotechnology of Actinobacteria 269 328 .
Andrew Currin, Neil SwainstonPhilip J. DayDouglas B. Kell. (2015) Synthetic biology for the directed evolution of protein biocatalysts: navigating sequence space intelligently. Chemical Society Reviews 44:5, pages 1172-1239.
Crossref
Christian Tiede, Anna A. S. Tang, Sarah E. Deacon, Upasana Mandal, Joanne E. Nettleship, Robin L. Owen, Suja E. George, David J. Harrison, Raymond J. Owens, Darren C. Tomlinson & Michael J. McPherson. (2014) Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications. Protein Engineering, Design and Selection 27:5, pages 145-155.
Crossref
Yoon Sup Choi, Soomin Yoon, Kyung-Lock Kim, Jiho Yoo, Parkyong Song, Minsoo Kim, Young-Eun Shin, Won Jun Yang, Jung-eun Noh, Hyun-soo Cho, Sanguk Kim, Junho Chung & Sung Ho Ryu. (2014) Computational Design of Binding Proteins to EGFR Domain II. PLoS ONE 9:4, pages e92513.
Crossref
Kritika Pershad & Brian K. Kay. (2013) Generating thermal stable variants of protein domains through phage display. Methods 60:1, pages 38-45.
Crossref
Martin Scholz & Angelika Lüking. (2012) A protein-stabilizing technology for enhanced antibody stability and antibody-binding profiles in a microchip array. Biotechnology Journal 7:8, pages 1002-1007.
Crossref
Agathe Urvoas, Asma Guellouz, Marie Valerio-Lepiniec, Marc Graille, Dominique Durand, Danielle C. Desravines, Herman van Tilbeurgh, Michel Desmadril & Philippe Minard. (2010) Design, Production and Molecular Structure of a New Family of Artificial Alpha-helicoidal Repeat Proteins (αRep) Based on Thermostable HEAT-like Repeats. Journal of Molecular Biology 404:2, pages 307-327.
Crossref
Markus A. Moosmeier, Julia Bulkescher, Jennifer Reed, Martina Schnölzer, Hans Heid, Karin Hoppe‐Seyler & Felix Hoppe‐Seyler. (2010) Transtactin: a universal transmembrane delivery system for Strep ‐tag II‐fused cargos . Journal of Cellular and Molecular Medicine 14:7, pages 1935-1945.
Crossref
Toni Hoffmann, Lukas Kurt Josef Stadler, Michael Busby, Qifeng Song, Anthony T. Buxton, Simon D. Wagner, Jason J. Davis & Paul Ko Ferrigno. (2010) Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant. Protein Engineering, Design and Selection 23:5, pages 403-413.
Crossref
Jan Terje Andersen & Inger Sandlie. 2009. Recombinant Antibodies for Immunotherapy. Recombinant Antibodies for Immunotherapy 293 310 .
Antoine Drevelle, Agathe Urvoas, Mériam Ben Hamida-Rebaï, Gérard Van Vooren, Magali Nicaise, Marie Valerio-Lepiniec, Michel Desmadril, Charles H. Robert & Philippe Minard. (2009) Disulfide Bond Substitution by Directed Evolution in an Engineered Binding Protein. ChemBioChem 10:8, pages 1349-1359.
Crossref
Caroline Grönwall & Stefan Ståhl. (2009) Engineered affinity proteins—Generation and applications. Journal of Biotechnology 140:3-4, pages 254-269.
Crossref
Agathe Urvoas, Philippe Minard & Patrice Soumillion. 2008. Protein Engineering Handbook. Protein Engineering Handbook 563 603 .
Fredrik Y. Frejd. 2008. Targeted Radionuclide Tumor Therapy. Targeted Radionuclide Tumor Therapy 89 116 .
Zhaozhong Han, Hailun Wang & Dennis E. Hallahan. (2016) Radiation-Guided Gene Therapy of Cancer. Technology in Cancer Research & Treatment 5:4, pages 437-444.
Crossref
Ferenc Zsila, Hisami Matsunaga, Zsolt Bikádi & Jun Haginaka. (2006) Multiple ligand-binding properties of the lipocalin member chicken α1-acid glycoprotein studied by circular dichroism and electronic absorption spectroscopy: The essential role of the conserved tryptophan residue. Biochimica et Biophysica Acta (BBA) - General Subjects 1760:8, pages 1248-1273.
Crossref
Zhaozhong Han, Ghazal Hariri & Dennis E. Hallahan. 2006. Multimodal Concepts for Integration of Cytotoxic Drugs. Multimodal Concepts for Integration of Cytotoxic Drugs 151 162 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.